You have 9 free searches left this month | for more free features.

City

Beijing (1)

New York (1)

Condition

Neuroendocrine Tumors (2)

Overall Status

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Molecular Targeting Technologies, Inc. (1)

Peking Union Medical College Hospital (1)

Collaborator

ClinSmart (1)

National Institute for Biomedical Imaging and Bioengineering (NIBIB) (1)

Intervention

177lu-dota-eb-tate (2)

amino acid solution (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

177lu-dota-eb-tate

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Neuroendocrine Tumors Trial in New York (177Lu-DOTA-EB-TATE, Amino Acid Solution)

Recruiting

Neuroendocrine Tumors

177Lu-DOTA-EB-TATE
Amino Acid Solution

New York, New York

Memorial Sloan Kettering Cancer Center

Jul 22, 2022

Neuroendocrine Tumors Trial in Beijing (177Lu-DOTA-EB-TATE)

Unknown status

Neuroendocrine Tumors

177Lu-DOTA-EB-TATE

Beijing, Beijing, China

Peking Union Medical College Hospital

Oct 8, 2017